Skip to main content

Arcadia Biosciences, Inc 10-Q for FY2026 Q3

Arcadia Biosciences, Inc. (RKDA)

10-Q 2026-11-12 For: 2026-09-30
View Original
Added on November 12, 2026

About this 10-Q

Arcadia Biosciences, Inc filed this 10-Q on November 12, 2026, covering the quarter ended September 30, 2026 (FY2026 Q3).

Arcadia reported nine-month product revenue growth of $205,000, or 5%, but a net loss of $8.9 million and cash of $2.8 million. Management raised substantial doubt about its going-concern status and disclosed material weaknesses in financial controls. AI summary

Headline figures

Quarter ended September 30, 2026, as reported in this filing, compared with the same period a year earlier where the filing states it.

Revenue
$1.62M
up 24.3% from $1.3M a year earlier
Net income
$1.76M
up 105.0% from net income of $856K a year earlier
Diluted EPS
$0.29
down 53.2% from $0.62 a year earlier